Short answer

Implement a standardized CSR measurement system that transparently reports on economic, environmental, and social performance to meet diverse stakeholder expectations.

Field
Innovation & Design
Source
International Journal of Management & Information Systems (IJMIS) (2010)
Method
Mixed-methods research, including analytical methods, interviews, desk research, and statistical analysis.
Sample
12 pharmaceutical companies
Evidence
Moderate effect

Developing a standardized measurement system for Corporate Social Responsibility (CSR) is crucial for the pharmaceutical industry to align stakeholder expectations and demonstrate accountability beyond profit. This innovation & design research insight is drawn from a 2010 study published in International Journal of Management & Information Systems (IJMIS). Using Mixed-methods research, including analytical methods, interviews, desk research, and statistical analysis. with 12 pharmaceutical companies, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Implement a standardized CSR measurement system that transparently reports on economic, environmental, and social performance to meet diverse stakeholder expectations.

Study
Innovation & DesignHigh ImpactModerate effect

A Unified Framework for Measuring Corporate Social Responsibility in the Pharmaceutical Sector

Developing a standardized measurement system for Corporate Social Responsibility (CSR) is crucial for the pharmaceutical industry to align stakeholder expectations and demonstrate accountability beyond profit.

International Journal of Management & Information Systems (IJMIS) · 2010

01

Key Findings

  • 01Limited and inconsistent application of CSR measurement systems in the pharmaceutical sector of the region.
  • 02A need exists to differentiate and standardize indicators for economic, environmental, and social performance.
  • 03Stakeholder theory provides a foundation for understanding the broader responsibilities of pharmaceutical companies.
02

Application

Design takeaway

Implement a standardized CSR measurement system that transparently reports on economic, environmental, and social performance to meet diverse stakeholder expectations.

How to apply

Companies can adapt the principles of stakeholder theory to develop their own CSR metrics, focusing on transparency and comprehensive reporting across all operational facets.

Project actions

  • 01When researching a company's impact, look beyond their financial reports to their environmental and social initiatives.
  • 02Consider how different groups (customers, employees, environment) are affected by a product or service.
03

Method & Evidence

AimTo analyze and propose a unified measurement system for Corporate Social Responsibility (CSR) within the pharmaceutical industry of a specific region, differentiating between economic, environmental, and social indicators.
MethodMixed-methods research, including analytical methods, interviews, desk research, and statistical analysis.
ProcedureThe study involved a detailed analysis of CSR measurement systems used by major pharmaceutical companies in four countries within the specified region, examining the indicators employed for economic, environmental, and social aspects.
Sample12 pharmaceutical companies
ContextPharmaceutical industry in ex-Yugoslavian countries (Slovenia, Croatia, Serbia, Bosnia and Herzegovina, Macedonia).

Variables

IVCSR measurement systems (economic, environmental, social indicators).
DVLevel of CSR adoption and consistency in the pharmaceutical industry.
CVPharmaceutical companies within the specified region.
04

Strengths & Limitations

Strengths

  • +Addresses a specific, under-researched area within CSR.
  • +Employs a multi-country regional focus.
  • +Utilizes a mixed-methods approach for comprehensive analysis.

Limitations

It can be challenging to find publicly available, standardized data for CSR metrics across different companies or industries.

Reliability & validity

Reliability would be enhanced by using standardized data collection methods for CSR indicators. Validity is supported by the theoretical grounding in stakeholder theory and the empirical analysis of existing practices.

Think critically

How can the 'success' of a design be measured if it has negative social or environmental consequences, even if it is highly profitable?

05

Design Principles

"Measure and report on the holistic impact of business operations, not just financial performance, to build trust and ensure long-term sustainability."

This research highlights a gap in how CSR is measured within the pharmaceutical sector, particularly in specific regions. By establishing a unified approach, companies can better communicate their commitment to social and environmental issues, fostering trust and potentially improving their overall brand reputation and market position.

06

What This Means for Your Design

Companies, especially in the drug industry, need a clear way to show they care about more than just making money. This study suggests a way to measure their good deeds for people and the planet, so everyone knows what they're doing.

How to use in your project

  • 1.Use the concept of stakeholder theory to justify the importance of measuring broader impacts beyond profit in your design project.
  • 2.Analyze how different stakeholders might perceive the success of your design based on various metrics (e.g., usability, environmental footprint, cost).
07

Add to My Project

08

Quick Cite

Paragraph starter

This research underscores the importance of a comprehensive approach to evaluating business performance, moving beyond purely economic indicators to encompass environmental and social responsibilities. By adopting a stakeholder-centric perspective, design projects can aim to create solutions that deliver value not only to the end-user but also to the wider community and ecosystem, fostering a more sustainable and ethical design practice.

09

Source

International Journal of Management & Information Systems (IJMIS)

A Measurement System Of Corporate Social Responsibility In The Pharmaceutical Industry Of The Region

journal · 2010

View source

Questions About This Research

What does the research say about a unified framework for measuring corporate social responsibility in the pharmaceutical sector?
Implement a standardized CSR measurement system that transparently reports on economic, environmental, and social performance to meet diverse stakeholder expectations. Evidence: International Journal of Management & Information Systems (IJMIS) (2010).
Why does "A Unified Framework for Measuring Corporate Social Responsibility in the Pharmaceutical Sector" matter for design?
This research highlights a gap in how CSR is measured within the pharmaceutical sector, particularly in specific regions. By establishing a unified approach, companies can better communicate their commitment to social and environmental issues, fostering trust and potentially improving their overall brand reputation and market position.
How can designers apply this research?
Implement a standardized CSR measurement system that transparently reports on economic, environmental, and social performance to meet diverse stakeholder expectations.
What were the main findings?
Limited and inconsistent application of CSR measurement systems in the pharmaceutical sector of the region.. A need exists to differentiate and standardize indicators for economic, environmental, and social performance.. Stakeholder theory provides a foundation for understanding the broader responsibilities of pharmaceutical companies.
What research method was used?
Mixed-methods research, including analytical methods, interviews, desk research, and statistical analysis. with 12 pharmaceutical companies.
How strong is the evidence?
Evidence strength is rated Moderate effect, based on a 2010 journal from International Journal of Management & Information Systems (IJMIS).
What should I do differently in my next project?
Companies can adapt the principles of stakeholder theory to develop their own CSR metrics, focusing on transparency and comprehensive reporting across all operational facets.
What are the limitations?
The study is focused on a specific region and may not be directly generalizable to pharmaceutical industries in other geographical areas. The sample size, while representative of key players, is limited.